Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17916806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg

Indicates status has not been verified in more than two years